Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable”

[Fill out the form below to register]

Abstract: The Global Clinical Research Organization (CRO) market is expected to grow to $71.7 billion in 2024. Within that growth, Functional Service Provider (FSP) relationships are expected to grow at a CAGR of 5%-6%. Sponsor organizations turn to the FSP model as an outsourcing strategy for multiple reasons. Efficiency, consistency, scalability, global reach, and cost reduction generally top that list. CROs, in turn, have evolved their culture, resourcing, and infrastructure to best suit FSP relationships

Given the increasing reliance on global support models, virtual work teams, and the complexity and increasing amounts of data and advancements in technology – sponsor organizations need more from their FSP partners.   The best-fit partners bring the functional line expertise plus an innovation mindset and tangible methods to identify, and where requested, help organizations to transform their way of operating.

Attendees will learn:

  • How FSP partners can go beyond “Global and Scalable”
  • How to bridge time zones and distance without compromising performance
  • How to create and maintain a culture of alignment with customer goals, standards, and results
  • Innovative methods for leading the charge to bring innovation and efficiencies
  • Sample innovations that have transformed FSP partnership operating models

This webinar is intended for small to mid-size organizations – those utilizing the FSP model today and those considering implementing FSP relationships in the future.

Presenters:

Donnelle LaDouceur, Director, Functional Service Solutions

Jim Balcom, Director, Innovation and Automation

Diederik Van Niekerk, Senior Manager, South Africa Operations

mms holdings fsp functional service provider provision webinar expert solutions services cro pharmaceutical biotech medical device industry biostatistics programming data science medical writing drug safety pharmacovigilance

Register for the webinar

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making